MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
1. MIRA announces positive preclinical data for Mira-55, a non-opioid pain relief. 2. Mira-55 offers morphine-equivalent analgesia without sedation or inflammation. 3. MIRA's merger with SKNY Pharmaceuticals progresses towards shareholder approval. 4. Mira-55 demonstrates potential in targeting underserved inflammatory pain markets. 5. MIRA focuses on advancing Mira-55 and Ketamir-2 towards clinical milestones.